Acetylcholinesterase Inhibitors May Improve Efficacy and Reduce Adverse Effects of Tricyclic Antidepressants for Depression

Author： Niederhofer Helmut  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.25, Iss.8, 2008-01, pp. : 715-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidepressants: a comparison of adverse effects

By  

Inpharma, Vol. 1, Iss. 1337, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites

By Rojas-Corrales M.O.   Casas J.   Moreno-Brea M.R.   Gibert-Rahola J.   Mico J.A.  

European Neuropsychopharmacology, Vol. 13, Iss. 5, 2003-10 ,pp. : 355-363

Elsevier

Access to resources Recommend Favorite

Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study

By Storosum J.G.   Elferink A.J.A.   van Zwieten B.J.   van den Brink W.   Gersons B.P.R.   van Strik R.   Broekmans A.W.  

European Neuropsychopharmacology, Vol. 11, Iss. 2, 2001-04 ,pp. : 173-180

Elsevier

Access to resources Recommend Favorite

Antidepressants may improve adherence to antiretroviral therapy

By  

Inpharma, Vol. 1, Iss. 1493, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

SNPs may reduce the efficacy of pravastatin

By  

Inpharma, Vol. 1, Iss. 1443, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite